| Analysis | Metabolite Name | Measured Value | Units | Sample type | Gender |
|---|---|---|---|---|---|
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 24929 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 26147 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 31157 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 32737 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 33140 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 37616 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 37739 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 38292 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 38902 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 39686 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 40479 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 41740 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 43667 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 46074 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 46640 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 46958 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 47700 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 47837 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 48697 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 49079 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 49822 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 52454 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 52501 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 53587 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 54020 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 54929 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 56374 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 56867 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 57618 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 57651 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 57917 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 57922 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 58212 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 58542 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 58794 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 58973 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 59244 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 59666 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 59730 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 60910 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 61182 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 61750 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 62011 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 63930 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 64538 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 65019 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 65301 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 65476 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 65687 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 65754 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 66142 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 66283 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 67888 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 69804 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 70486 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 70590 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 70603 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 70719 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 71837 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 72134 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 72441 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 72702 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 72853 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 73067 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 73130 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 73637 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 73665 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 73696 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 73993 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 74177 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 74626 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 74797 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 74819 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 75853 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 76280 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 76756 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 77057 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 78267 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 78400 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 79119 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 79464 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 81418 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 81699 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 82271 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 82717 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 83018 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 83323 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 83360 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 85154 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 85466 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 85493 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 86045 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 86642 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 87104 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 88529 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 89268 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 89950 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 90128 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 90139 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 91654 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 92596 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 92802 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 93510 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 93784 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 94107 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 94704 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 95047 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 95412 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 95555 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 95588 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 95605 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 96916 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 97767 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 98753 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 99899 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 100691 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 100853 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 100915 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 104943 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 104945 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 106580 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 108485 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 110476 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 113489 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 113547 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 115452 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 116633 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 117556 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 117673 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 120747 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 123423 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 123683 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 126537 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 126780 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 130300 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 132786 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 132890 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 134416 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 139467 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 141303 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 142020 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 144793 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 147799 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 147948 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 147970 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 148517 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 148579 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 151053 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 152444 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 154134 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 155301 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 155477 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 155602 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 156305 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 157257 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 157403 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 157728 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 157954 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 158292 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 158539 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 158756 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 158955 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 159439 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 159474 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 159503 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 159629 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 159887 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 160276 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 160327 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 160480 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 160590 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 160655 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 160816 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 160863 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 160923 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 160974 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 161035 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 161096 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 161147 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 161200 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 161330 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 161406 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 161433 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 161688 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 161753 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 162092 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 162129 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 162168 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 162606 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 162677 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 162864 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 162867 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 163018 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 163075 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 163147 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 163197 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 163421 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 163810 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 164426 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(12:0) | 165220 | Peak area normalized | Sample | male |
Return to search page
